Отчет об анализе размера, доли и тенденций мирового рынка АФИ ибупрофена – обзор отрасли и прогноз до 2031 года

Анализ и размер рынка API ибупрофена

Глобальный рынок API ибупрофена переживает устойчивый рост, обусловленный растущим спросом на безрецептурные (OTC) обезболивающие и противовоспалительные препараты. Рост хронических заболеваний, таких как артрит  и мигрени, наряду с растущей распространенностью таких распространенных заболеваний, как простуда и грипп, подпитывает потребность в эффективных решениях по лечению боли. Кроме того, расширение фармацевтической промышленности на развивающихся рынках и продолжающиеся инновации в лекарственных формулах способствуют расширению рынка. Ключевые игроки в отрасли сосредоточены на повышении чистоты и эффективности производства API ибупрофена для соответствия строгим нормативным стандартам и повышения эффективности продукта.

Размер рынка API ибупрофена

Объем мирового рынка АФИ ибупрофена оценивался в 448,74 млн долларов США в 2023 году и, по прогнозам, достигнет 657,96 млн долларов США к 2031 году, при среднегодовом темпе роста 4,90% в прогнозируемый период с 2024 по 2031 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, географически представленное производство и мощности компаний, сетевые схемы дистрибьюторов и партнеров, подробный и обновленный анализ ценовых тенденций и анализ дефицита цепочки поставок и спроса.

Область отчета и сегментация рынка       

Ibuprofen API Market Definition

Ibuprofen API is the pure, active substance used in the manufacture of ibuprofen-based medications. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, and inflammation. The API is the core component that provides the therapeutic effects of ibuprofen when formulated into tablets, capsules, or other dosage forms.

Ibuprofen API Market Dynamics

Drivers

• Increasing Demand for Pain Management

As the global population ages and lifestyle-related health issues become more common, the need for reliable pain management solutions continues to grow. Chronic conditions such as arthritis, back pain, and migraines contribute to the sustained demand for nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. This heightened demand for pain relief drives the need for more ibuprofen API, ensuring that pharmaceutical companies can produce sufficient quantities to meet market requirements. The rising prevalence of chronic pain conditions and common ailments significantly boosts the demand for effective ibuprofen-based treatments.

• Rising Demand for Ibuprofen Expanding Pharmaceutical Sector 

With developing economies investing more in healthcare infrastructure and increasing their pharmaceutical manufacturing capabilities, there is a rising need for active pharmaceutical ingredients, including ibuprofen. The growth in these markets is fueled by increased healthcare access, higher disposable incomes, and a growing focus on improving healthcare outcomes. Consequently, this expansion presents significant opportunities for ibuprofen API suppliers to tap into new markets and leverage the growing demand for pain management solutions. The expansion of the pharmaceutical sector, especially in emerging markets, is a key factor driving the increased demand for ibuprofen APIs.

Opportunities

• Rising OTC Medication Sales

Consumers are increasingly opting for OTC medications due to their convenience and accessibility compared to prescription drugs. This trend is fueled by a greater emphasis on self-care and the desire to manage minor health issues independently. As more people seek OTC solutions for pain relief and inflammation, the need for ibuprofen APIs rises to support the production of these widely used medications. This shift towards OTC products creates significant growth opportunities for manufacturers of ibuprofen APIs.       

• Advancements in ibuprofen Drug Formulations            

Ongoing innovation in drug delivery and formulation technologies is enhancing the efficacy and market appeal of ibuprofen products. Advancements such as controlled-release formulations, combination therapies, and improved absorption techniques are making ibuprofen more effective and appealing to both consumers and healthcare providers. These innovations not only improve patient compliance and therapeutic outcomes but also create new opportunities for ibuprofen API manufacturers to differentiate their products in a competitive market. The ability to offer advanced formulations that cater to specific patient needs helps drive demand for high-quality ibuprofen APIs.

Restraints/Challenges

• Fluctuating Raw Material Prices    

Volatility in the prices of raw materials used in ibuprofen API production can significantly impact profitability and market stability. Key ingredients for producing ibuprofen, such as chemicals and intermediates, are subject to price fluctuations due to various factors, including supply chain disruptions, geopolitical tensions, and changes in global commodity markets. These price variations can lead to increased production costs, which may necessitate adjustments in the ibuprofen API price.       

• Side Effects and Safety Concerns 

Potential side effects and safety issues associated with ibuprofen can influence consumer confidence and affect market demand. While ibuprofen is widely used for pain relief and inflammation, it is associated with several adverse effects, including gastrointestinal disturbances, cardiovascular risks, and renal complications. These safety concerns can lead to regulatory scrutiny and impact public perception of the drug. Ensuring rigorous testing, transparent labeling, and comprehensive risk communication are crucial for addressing these issues.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In November 2022, Solara Active Pharma Sciences Limited's state-of-the-art, multipurpose API manufacturing facility in Vishakhapatnam, Andhra Pradesh, obtained Certificate of Suitability (CEP) approval from the European Directorate for the Quality of Medicine (EDQM) for ibuprofen API production
• In March 2022, Lonza invested USD 935 million in new sites in Portsmouth, New Hampshire, and Visp, Switzerland. The company also completed a laboratory expansion at its API manufacturing facility in Nansha, China

Ibuprofen API Market Scope

The market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Standard Ibuprofen
• High Potency Ibuprofen

Application

• Headache
• Arthritis
• Others

End User

• CROs and CMOs
• Pharmaceutical and Biopharmaceutical Companies

Ibuprofen API Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, type, application, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

Asia-Pacific is expected to dominate the market due to increased healthcare expenditure, growth in production facilities, a strong presence of pharmaceutical and biotechnological key players, a rising incidence of rheumatoid arthritis, and an overall surge in healthcare activities.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции, анализ пяти сил Портера и тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность региональных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговые пути.

Анализ доли рынка API ибупрофена

Конкурентная среда рынка содержит сведения о конкурентах. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в НИОКР, новых рыночных инициативах, региональном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта и доминировании приложений. Приведенные выше данные касаются только фокуса компаний на рынке.

На рынке работают следующие основные игроки:

• BASF SE (Германия)
• SI Group, Inc. (США)
• BIOCAUSE Inc. (США)
• IOL Chemicals and Pharmaceuticals Limited (Индия)
• Цзыбо Синьхуа-Перриго Фармасьютикал Ко., Лтд. (Китай)
• Granules India Limited (Индия)
• LGM Pharma (США)
• Сальвавидас (Индия)
• Taj Pharmaceuticals Limited (Индия)

SKU-60880